Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

Advanced Health Intelligence Ltd

Technology AU AHI

0.092AUD
-(-%)

Last update at 2024-10-08T23:00:00Z

Day Range

0.090.09
LowHigh

52 Week Range

0.080.17
LowHigh

Fundamentals

  • Previous Close 0.09
  • Market Cap20.03M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-14.07484M
  • Revenue TTM-0.92486M
  • Revenue Per Share TTM-0.004
  • Gross Profit TTM -5.77185M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -12.82718M -20.96696M -14.84540M -6.06273M -4.88880M
Minority interest - - - - -
Net income -12.82718M -20.07684M -14.06099M -5.39651M -4.35716M
Selling general administrative 5.68M 17.14M 10.67M 4.66M 4.59M
Selling and marketing expenses 0.91M 2.11M 1.23M 1.37M 0.30M
Gross profit -4.67235M -3.17142M -9.29286M -3.75957M -3.81924M
Reconciled depreciation 0.31M 0.36M 0.35M 0.25M 0.20M
Ebit -10.16427M -19.18040M -11.94346M -6.02175M -4.79828M
Ebitda -9.79300M -18.81670M -11.57977M -5.67237M -4.55263M
Depreciation and amortization 0.37M 0.36M 0.36M 0.35M 0.25M
Non operating income net other - - - - -
Operating income -12.60389M -21.40157M -11.92915M -5.91801M -4.75220M
Other operating expenses 11.01M 19.77M 13.34M 6.73M 5.65M
Interest expense 0.48M 0.16M 0.25M 0.14M 0.14M
Tax provision 0.00000M -0.89011M -0.78441M -0.66622M -0.53164M
Interest income 1.99M 0.15M 0.10M 0.00001M 0.00009M
Net interest income -0.22329M -0.00857M -0.20854M -0.14357M -0.13651M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.48M -0.89011M -0.78441M -0.66622M -0.53164M
Total revenue 0.65M 0.26M 0.59M 0.14M 0.00464M
Total operating expenses 5.69M 19.77M 13.34M 6.73M 5.65M
Cost of revenue 5.33M 3.43M 9.89M 3.90M 3.82M
Total other income expense net -2.24394M -1.45057M -1.89460M 0.67M 0.89M
Discontinued operations - - - - -
Net income from continuing ops -12.82718M -20.07684M -14.06099M -5.39651M -4.35716M
Net income applicable to common shares -12.82718M -22.64193M -14.06099M -5.39651M -4.35716M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 8.91M 10.66M 5.42M 2.95M 2.63M
Intangible assets 4.31M 0.97M 1.22M 1.37M 1.45M
Earning assets - - - - -
Other current assets - - 0.86M 0.29M -
Total liab 6.88M 2.11M 3.44M 2.49M 2.08M
Total stockholder equity 2.03M 8.56M 1.98M 0.46M 0.55M
Deferred long term liab - - - - -
Other current liab 0.43M 0.75M 1.31M 0.75M 0.48M
Common stock 76.01M 61.82M 39.21M 24.36M 13.78M
Capital stock 76.01M 61.82M 39.21M 24.36M 13.78M
Retained earnings -75.29900M -62.60557M -42.52873M -28.46954M -23.16356M
Other liab 0.55M 0.06M - - -
Good will 3.21M - - - -
Other assets 0.07M 0.04M 0.04M 0.11M 0.52M
Cash 2.10M 6.01M 2.17M 0.63M 0.57M
Cash and equivalents - - - - -
Total current liabilities 6.03M 2.05M 3.39M 2.03M 2.08M
Current deferred revenue - - 0.13M - -
Net debt - -4.84998M 0.14M 0.77M 0.92M
Short term debt 1.43M 1.16M 2.27M 0.93M 1.50M
Short long term debt 1.43M 1.11M 2.18M 0.86M 1.50M
Short long term debt total - 1.16M 2.32M 1.39M 1.50M
Other stockholder equity 1.32M 9.34M 5.29M 4.58M 9.93M
Property plant equipment 0.51M 0.13M 0.16M 0.25M 0.06M
Total current assets 3.25M 6.96M 3.32M 1.22M 0.60M
Long term investments 0.76M 2.57M 0.04M 0.04M 0.04M
Net tangible assets -2.28583M 5.02M 0.76M -0.91099M -0.90235M
Short term investments - - - - -
Net receivables 0.31M 0.05M 0.24M 0.29M 0.03M
Long term debt - - 0.00000M 0.32M 0.00000M
Inventory - - 0.00000M 0.00473M 0.00476M
Accounts payable 2.81M 0.14M 0.34M 0.34M 0.10M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 9.34M 5.29M 4.58M 9.93M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - 0.68M 0.07M 0.48M
Deferred long term asset charges - - - - -
Non current assets total 5.66M 3.71M 2.10M 1.73M 2.03M
Capital lease obligations 0.37M 0.05M 0.14M 0.21M -
Long term debt total 0.31M 0.00000M 0.05M 0.46M 0.00000M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments 0.13M -3.12695M -2.76094M -2.76094M -2.76094M
Change to liabilities 3.03M -0.18709M -0.05304M 0.45M -0.03966M
Total cashflows from investing activities -0.66926M -3.38472M -3.44213M -0.08468M -0.24220M
Net borrowings -0.33798M 0.99M 0.85M 0.91M 0.90M
Total cash from financing activities 4.17M 17.08M 9.12M 2.84M 3.90M
Change to operating activities 0.44M 0.02M -0.48426M 0.11M -0.49294M
Net income -12.82718M -20.07684M -14.06099M -5.39651M -4.35716M
Change in cash -3.90678M 3.84M 1.55M 0.05M 0.40M
Begin period cash flow 6.01M 2.17M 0.63M 0.57M 0.17M
End period cash flow 2.10M 6.01M 2.17M 0.63M 0.57M
Total cash from operating activities -7.36718M -7.29372M -4.10209M -2.69726M -3.25880M
Issuance of capital stock 5.00M 18.23M 8.63M 2.05M 3.20M
Depreciation 0.37M 0.36M 0.11M 0.07M 0.03M
Other cashflows from investing activities 0.12M -0.17150M 0.07M 0.08M -0.15000M
Dividends paid 0.00000M - 2.15M 1.73M 1.55M
Change to inventory 0.00000M -0.00711M 0.00473M 0.00003M 0.00003M
Change to account receivables -0.23495M 0.19M 0.05M -0.26870M 0.11M
Sale purchase of stock 5.00M 23.99M -0.39698M -0.12300M -0.19680M
Other cashflows from financing activities 3.73M -1.06402M 1.75M 1.61M 1.35M
Change to netincome 1.85M 12.40M 10.09M 2.17M 1.32M
Capital expenditures 0.07M 0.09M 0.09M 0.17M 0.09M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 3.24M 0.02M 0.86M 1.33M 0.65M
Stock based compensation 0.22M 8.43M 7.30M 2.07M 1.21M
Other non cash items -0.13641M 12.99M 2.80M 0.09M 1.99M
Free cash flow -7.43467M -7.37999M -0.08815M -0.16618M -0.09220M

Peer Comparison

Sector: Technology Industry: Software - Application

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AHI
Advanced Health Intelligence Ltd		 - -% 0.09 - - 30.59 9.88 30.13 -1.6389
WTC
WiseTech Global Limited		 -2.04 1.87% 106.89 117.39 105.26 51.73 15.06 31.77 71.45
XRO
Xero Ltd		 -1.68 0.87% 191.88 144.43 96.15 14.02 15.00 15.19 41.63
TNE
Technology One Ltd		 -0.6 1.46% 40.55 105.46 85.47 24.41 33.56 25.02 54.79
NWL
Netwealth Group Ltd		 -0.27 0.87% 30.80 78.46 51.55 27.44 44.07 28.50

Reports Covered

Stock Research & News

View All

Profile

Advanced Health Intelligence Ltd. operates as a mobile application and technology development company in Australia and internationally. It offers biometric health assessments, a multi-step process that employs facial scanning, heart rate measurements, body composition analysis, and cardiovascular fitness tests that evaluates an individual's health. The company also provides FaceScan, process that estimates on heart rate, respiration rate, blood pressure, and other through facial scans; BodyScan, a smart body composition and dimensioning technology that enables user to check and assess body dimensions using a smartphone; and DermaScan, a dermatological scanner. It serves mobile health and telehealth, life and health insurance, wellness, and government sectors. The company was formerly known as Advanced Human Imaging Limited and changed its name to Advanced Health Intelligence Ltd. in December 2022. Advanced Health Intelligence Ltd. was incorporated in 2014 and is based in South Perth, Australia.

Advanced Health Intelligence Ltd

71-73 South Perth Esplanade, South Perth, WA, Australia, 6151

Key Executives

Name Title Year Born
Dr. Katherine Iscoe B.A, B.A., M.Sc., MSc, Ph.D. Co-Founder & Exec. Director NA
Mr. Vlado Bosanac Co-Founder & Head of Strategy 1967
Mr. Simon Durack B.Com., F.C.A., FCIS, J.P. CFO & Company Sec. NA
Mr. Scott Montgomery CEO & Exec. Director NA
Ms. Nadine Amesz Operations Officer NA
Mr. Terence Stupple Chief Technology Officer 1979
Dr. Amar El-Sallam Chief Science Officer 1972
Ms. Anita Swan Marketing Director NA
Mr. Ryan Snowden Chief Design Officer NA
Mr. Brian Kirkbride Strategic Advisor NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.